OpenADMET published a Practical Cheminformatics post examining how agent workflows can reduce friction when evaluating computational methods and foundation models using real-world ADMET datasets from the OpenADMET ExpansionRx Blind Challenge and Biogen.
Public source
Publisher name
Public post
In the latest Practical Cheminformatics post, I examine how agent workflows can reduce friction when evaluating computational methods and foundation models. Instead of s…
Company
OpenADMET
Next generation ADMET modeling for therapeutic development
- Industry
- Biotechnology Research
- Company size
- 2–10 employees
About OpenADMET
Next generation ADMET modeling for therapeutic development
See moreLatest activity
Latest activity from OpenADMET
7 signals
Products & Services
OpenADMET launched Model Validation Central, a platform for re-running published molecular ML methods on the ExpansionRx and Biogen ADME datasets across 25 replicates.
Presence & Recognition
OpenADMET released a video in the OpenADMET seminar series featuring Matt Robinson from PostEra exploring the confusing mess of units in ADME and PK data.
Presence & Recognition
OpenADMET hosted a new webinar featuring top performers from the activity prediction component of the OpenADMET PXR Blind Challenge.
Discover more
Similar signals
Similar public activity from other companies.
Research & Knowledge
Insilico Medicine
Insilico Medicine released new SOTA+ drug discovery models for drug safety and metabolism prediction, including InsilicoMMAI-Chem-ADMET, which reaches SOTA+ performance on 7 ADMET tasks.
Research & Knowledge
Excelra
Excelra published a blog exploring how better data foundations can make LLM-driven chemistry workflows more reliable.
Research & Knowledge
Apheris
Apheris released OpenBind-0, an open co-folding model that ships with 717 ligand-bound structures from fragment-to-hit campaigns on three real discovery targets.
Research & Knowledge
Agrematch
Agrematch's VP Business Development Ouri Fischel published an article exploring how chemistry-specific predictive AI helps R&D teams re-evaluate accumulated knowledge against new requirements.
Research & Knowledge
Pharmacelera